Balasa Dinverno & Foltz LLC Viatris Inc Transaction History
Balasa Dinverno & Foltz LLC
- $1.58 Billion
- Q3 2022
A detailed history of Balasa Dinverno & Foltz LLC transactions in Viatris Inc stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 20,908 shares of VTRS stock, worth $242,741. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,908Holding current value
$242,741% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding VTRS
# of Institutions
1,100Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.63 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.08 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$721 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$668 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$660 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...